4.6 Article

Roles for Ordered and Bulk Solvent in Ligand Recognition and Docking in Two Related Cavities

Journal

PLOS ONE
Volume 8, Issue 7, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0069153

Keywords

-

Funding

  1. US NIH [GM59957]
  2. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041049, R01GM059957] Funding Source: NIH RePORTER

Ask authors/readers for more resources

A key challenge in structure-based discovery is accounting for modulation of protein-ligand interactions by ordered and bulk solvent. To investigate this, we compared ligand binding to a buried cavity in Cytochrome c Peroxidase (CcP), where affinity is dominated by a single ionic interaction, versus a cavity variant partly opened to solvent by loop deletion. This opening had unexpected effects on ligand orientation, affinity, and ordered water structure. Some ligands lost over ten-fold in affinity and reoriented in the cavity, while others retained their geometries, formed new interactions with water networks, and improved affinity. To test our ability to discover new ligands against this opened site prospectively, a 534,000 fragment library was docked against the open cavity using two models of ligand solvation. Using an older solvation model that prioritized many neutral molecules, three such uncharged docking hits were tested, none of which was observed to bind; these molecules were not highly ranked by the new, context-dependent solvation score. Using this new method, another 15 highly-ranked molecules were tested for binding. In contrast to the previous result, 14 of these bound detectably, with affinities ranging from 8 mu M to 2 mM. In crystal structures, four of these new ligands superposed well with the docking predictions but two did not, reflecting unanticipated interactions with newly ordered waters molecules. Comparing recognition between this open cavity and its buried analog begins to isolate the roles of ordered solvent in a system that lends itself readily to prospective testing and that may be broadly useful to the community.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

Modelling covalent linkages in CCP4

Robert A. Nicholls, Robbie P. Joosten, Fei Long, Marcin Wojdyr, Andrey Lebedev, Eugene Krissinel, Lucrezia Catapano, Marcus Fischer, Paul Emsley, Garib N. Murshudov

Summary: This article discusses the protocols and tools for modelling covalent linkages within the CCP4 suite, including the generation of link dictionaries and the use of various tools for covalent linkage modelling. These integrated solutions streamline the workflow and aim to improve the quality of future modelled covalent linkages.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2021)

Article Biochemical Research Methods

The missing link: covalent linkages in structural models

Robert A. Nicholls, Marcin Wojdyr, Robbie P. Joosten, Lucrezia Catapano, Fei Long, Marcus Fischer, Paul Emsley, Garib N. Murshudov

Summary: This study evaluates the issues with covalent linkages in the Protein Data Bank, aiming to remediate existing models and improve the quality of future linkages. By analyzing the CCP4 Monomer Library, it is found that failure to model a covalent linkage results in inaccurate interatomic distances. The recent expansion of the CCP4-ML with additional dictionaries and link dictionaries will aid in identifying and applying linkage types in future modeling efforts.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2021)

Article Hematology

Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia

Yunchao Chang, Jaeki Min, Jamie A. Jarusiewicz, Marisa Actis, Shanshan Yu-Chen Bradford, Anand Mayasundari, Lei Yang, Divyabharathi Chepyala, Lisa J. Alcock, Kathryn G. Roberts, Stanley Nithianantham, Dylan Maxwell, Lauren Rowland, Randolph Larsen, Aman Seth, Hiroaki Goto, Toshihiko Imamura, Koshi Akahane, Baranda S. Hansen, Shondra M. Pruett-Miller, Elisabeth M. Paietta, Mark R. Litzow, Chunxu Qu, Jun J. Yang, Marcus Fischer, Zoran Rankovic, Charles G. Mullighan

Summary: The study evaluated the efficacy of proteolysis-targeting chimeras (PROTACs) against JAKs, and developed multiple PROTACs that could degrade JAKs and effectively inhibit CRLF2r cell lines, with one compound showing the potential to suppress the proliferation of CRLF2r ALL in vivo. This highlights the potential of JAK-directed protein degradation as a therapeutic approach in JAK-STAT-driven ALL.

BLOOD (2021)

Article Chemistry, Medicinal

Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators

Gisele Nishiguchi, Fatemeh Keramatnia, Jaeki Min, Yunchao Chang, Barbara Jonchere, Sourav Das, Marisa Actis, Jeanine Price, Divyabharathi Chepyala, Brandon Young, Kevin McGowan, P. Jake Slavish, Anand Mayasundari, Jamie A. Jarusiewicz, Lei Yang, Yong Li, Xiang Fu, Shalandus H. Garrett, James B. Papizan, Kiran Kodali, Junmin Peng, Shondra M. Pruett Miller, Martine F. Roussel, Charles Mullighan, Marcus Fischer, Zoran Rankovic

Summary: This study describes the design, synthesis, and screening of a large diverse library of thalidomide analogues against leukemia and medulloblastoma cell lines, leading to the discovery of potent GSPT1/2 degraders with selectivity over IMiD neosubstrates and high oral bioavailability in mice. Compound 6 (SJ6986) is proposed as a valuable tool for studying the role of GSPT1/2 and supports the utility of a diverse library of CRBN binders in targeting undruggable oncoproteins.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

New Design Rules for Developing Potent Cell-Active Inhibitors of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition

Huda Zahid, Caroline R. Buchholz, Manjulata Singh, Michael F. Ciccone, Alice Chan, Stanley Nithianantham, Ke Shi, Hideki Aihara, Marcus Fischer, Ernst Schonbrunn, Camila O. dos Santos, Joseph W. Landry, William C. K. Pomerantz

Summary: This study describes the development of pyridazinone-based BPTF inhibitors, with the lead compound BZ1 showing high potency and selectivity over BET bromodomains. The inhibitors sensitized breast cancer cells to doxorubicin, indicating specificity to BPTF. The findings suggest that these inhibitors could serve as starting points for exploring the biological roles of BPTF.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs

Jaeki Min, Anand Mayasundari, Fatemeh Keramatnia, Barbara Jonchere, Seung Wook Yang, Jamie Jarusiewicz, Marisa Actis, Sourav Das, Brandon Young, Jake Slavish, Lei Yang, Yong Li, Xiang Fu, Shalandus H. Garrett, Mi-Kyung Yun, Zhenmei Li, Stanley Nithianantham, Sergio Chai, Taosheng Chen, Anang Shelat, Richard E. Lee, Gisele Nishiguchi, Stephen W. White, Martine F. Roussel, Patrick Ryan Potts, Marcus Fischer, Zoran Rankovic

Summary: IMiDs and IMiD-based PROTACs rapidly hydrolyze in commonly utilized cell media, affecting their efficacy; Novel CRBN binders, phenyl glutarimide (PG) analogues, were designed with high affinity and improved stability; Discovery of PG PROTAC 4c as a potent degrader of BET proteins, supporting the utility of PG derivatives in CRBN-directed PROTACs design.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Chemistry, Medicinal

Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACs

Lisa J. Alcock, Yunchao Chang, Jamie A. Jarusiewicz, Marisa Actis, Stanley Nithianantham, Anand Mayasundari, Jaeki Min, Dylan Maxwell, Jeremy Hunt, Brandon Smart, Jun J. Yang, Gisele Nishiguchi, Marcus Fischer, Charles G. Mullighan, Zoran Rankovic

Summary: The study describes the design and synthesis of JAK2/3 PROTACs and their potency in patient-derived ALL cells. SJ10542 showed high selectivity and potency, making it a promising candidate for the treatment of hematological malignancies.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Chemistry, Multidisciplinary

Water Networks Repopulate Protein-Ligand Interfaces with Temperature

Timothy R. Stachowski, Murugendra Vanarotti, Jayaraman Seetharaman, Karlo Lopez, Marcus Fischer

Summary: High-resolution crystal structures have shown the importance of water networks in protein-ligand interactions. This study compares room-temperature and cryogenic datasets to identify changes in water networks that affect protein conformations and ligand interactions. The results reveal temperature and ligand-sensitive regions in the protein structure, providing insights for discovering selective ligands and utilizing hidden protein and water conformations in drug discovery.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Chemistry, Medicinal

Large-Scale Ligand Perturbations of the Protein Conformational Landscape Reveal State-Specific Interaction Hotspots

Timothy R. Stachowski, Marcus Fischer

Summary: Protein flexibility is crucial in drug design, especially for targeting dynamic proteins like Hsp90. The analysis of Hsp90 alpha crystal structures revealed different conformations of the lid domain that accommodate chemically distinct ligands. This study highlights the importance of considering protein ensembles and warns against overinterpreting individual crystal structures in drug design.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Hematology

The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia

Yunchao Chang, Fatemeh Keramatnia, Pankaj S. Ghate, Gisele Nishiguchi, Qingsong Gao, Ilaria Iacobucci, Lei Yang, Divyabharathi Chepyala, Ashutosh Mishra, Anthony A. High, Hiroaki Goto, Koshi Akahane, Junmin Peng, Jun J. Yang, Marcus Fischer, Zoran Rankovic, Charles G. Mullighan

Summary: This study developed a novel cereblon modulator named SJ6986, which effectively degrades GSPT1 and GSPT2 and exhibits cytotoxic activity against childhood cancer cell lines. In vitro and in vivo testing showed that SJ6986 has similar cytotoxicity to the previously described GSPT1 degrader CC-90009, but is more effective in suppressing leukemic cell growth and does not significantly impair differentiation of human CD34(+) cells. Genome-wide CRISPR/Cas9 screening confirmed the involvement of components of the CRL4CRBN complex in mediating the action of SJ6986. SJ6986 is a potent and selective GSPT1/2 degrader with broad antileukemic activity and potential for clinical development.

BLOOD (2023)

Article Chemistry, Medicinal

From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors

Mladen Koravovic, Anand Mayasundari, Gordana Tasic, Fatemeh Keramatnia, Timothy R. Stachowski, Huarui Cui, Sergio C. Chai, Barbara Jonchere, Lei Yang, Yong Li, Xiang Fu, Ryan Hiltenbrand, Leena Paul, Vibhor Mishra, Jeffery M. Klco, Martine F. Roussel, William CK. Pomerantz, Marcus Fischer, Zoran Rankovic, Vladimir Savic

Summary: An X-ray structure of a CLICK chemistry-based BET PROTAC bound to BRD2(BD2) inspired the synthesis of JQ1 derived heterocyclic amides. These compounds displayed improved profiles compared to JQ1 and birabresib as potent BET inhibitors. A specific compound 1q (SJ1461) showed excellent affinity to both BRD4 and BRD2 and high potency in acute leukaemia and medulloblastoma cell lines. The co-crystal structure of 1q with BRD4-BD1 revealed polar interactions, explaining the observed affinity improvements. Furthermore, pharmacokinetic studies suggested that the heterocyclic amide moiety improved drug-like features. Our study led to the discovery of the potent and orally bioavailable BET inhibitor 1q (SJ1461) as a promising candidate for further development.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Pan-HSP90 ligand binding reveals isoform-specific differences in plasticity and water networks

Timothy R. R. Stachowski, Stanley Nithianantham, Murugendra Vanarotti, Karlo Lopez, Marcus Fischer

Summary: Isoforms of HSP90 play a role in facilitating cancer development, but their therapeutic potential remains unfulfilled due to lack of FDA-approved drugs. The challenge lies in selective targeting of isoforms with high structural similarity and side effects caused by pan-HSP90 inhibition. This study presents a three-pronged approach to understand the HSP90 landscape and explore isoform-specific accommodations, shedding light on ligand discovery and design for potential drug development.

PROTEIN SCIENCE (2023)

Article Biochemical Research Methods

FLEXR: automated multi-conformer model building using electron-density map sampling

Timothy R. Stachowski, Marcus Fischer

Summary: Researchers have developed an automated multi-conformer modeling program, FLEXR, to detect and include hidden protein conformational dynamics in high-resolution electron-density maps. The program reveals new structural details that are missed by manual modeling or current tools, such as hidden side chains and backbone conformations in ligand-binding sites, which may redefine protein-ligand binding mechanisms. FLEXR is an open-source tool available for crystallographers.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2023)

Article Chemistry, Multidisciplinary

Temperature artifacts in protein structures bias ligand-binding predictions

Shanshan Y. C. Bradford, Lea El Khoury, Yunhui Ge, Meghan Osato, David L. Mobley, Marcus Fischer

Summary: By systematically investigating protein conformational changes in response to temperature and ligand binding, new global and local structural changes were revealed in the T4 lysozyme L99A cavity when shifting to room temperature. Temperature-induced alterations in protein and ligand structures can influence computational methods and the utility of structural information in ligand binding predictions, highlighting the potential limitations of relying solely on cryogenic data for computational purposes.

CHEMICAL SCIENCE (2021)

Review Biophysics

Macromolecular room temperature crystallography

Marcus Fischer

Summary: This review discusses practical aspects of preparing, acquiring, and analyzing X-ray crystallography data at room temperature, aiming to demystify preconceived impracticalities that freeze progress of routine room temperature data collection at synchrotron sources. Examples are provided as conceptual and experimental templates, illustrating the diversity and utility of gaining novel insights into protein conformational landscapes. An integrative view of protein conformational dynamics offers opportunities to advance basic and biomedical research.

QUARTERLY REVIEWS OF BIOPHYSICS (2021)

No Data Available